Concepedia

Nicola Lawson

NL

4

Publications

144

Citations

4

H-Index

2017

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Nicola Lawson is an author at AstraZeneca (United Kingdom) specializing in molecular diagnostics, medicine, and prognostic biomarkers.

ORCID

Top concepts

Publications per year

2017–2023

4

Publications

4

Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

Nicola Lawson, Carly I. Dix, Paul W. Scorer et al. · Modern Pathology · 2019 · 85 citations · Full text

Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay

Paul Scorer, Marietta Scott, Nicola Lawson et al. · Diagnostic Pathology · 2018 · 36 citations · Full text

Impact of Decalcification, Cold Ischemia, and Deglycosylation on Performance of Programmed Cell Death Ligand-1 Antibodies With Different Binding Epitopes: Comparison of 7 Clones

Nicola Lawson, Paul W. Scorer, Gareth Williams et al. · Modern Pathology · 2023 · 12 citations

Assessment of heterogeneity of PD-L1 expression in NSCLC, HNSCC, and UC with Ventana SP263 assay.

Marietta Scott, Paul Scorer, Nicola Lawson et al. · Journal of Clinical Oncology · 2017 · 11 citations

, , +22

Rows per page

1–4 of 4